Publicacións en colaboración con investigadores/as de Universitat de Barcelona (18)

2024

  1. Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis

    Autoimmunity Reviews

2023

  1. Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review

    Respiratory Medicine, Vol. 214

2022

  1. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

    European Respiratory Journal

2020

  1. Author Correction: Validating a breast cancer score in Spanish women. The MCC-Spain study (Scientific Reports, (2018), 8, 1, (3036), 10.1038/s41598-018-20832-0)

    Scientific Reports

2018

  1. The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up

    Archivos de Bronconeumologia, Vol. 54, Núm. 7, pp. 378-385

  2. Validating a breast cancer score in Spanish women. The MCC-Spain study

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case–control study

    International Journal of Cancer, Vol. 141, Núm. 1, pp. 83-93

2014

  1. Do nutritional supplements have a role in age macular degeneration prevention?

    Journal of Ophthalmology, Vol. 2014

2002

  1. Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine

    Antiviral Therapy, Vol. 7, Núm. 4, pp. 283-287

2001

  1. Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 560 × 106/1 [6]

    AIDS

  2. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

    AIDS, Vol. 15, Núm. 9

2000

  1. Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus- infected patients receiving antiretroviral therapy

    Clinical Infectious Diseases, Vol. 30, Núm. 2, pp. 392-394

1999

  1. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

    AIDS, Vol. 13, Núm. 11

1998

  1. Changes in HIV-1 RNA viral load following tuberculin skin test [7]

    Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

  2. Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection

    AIDS, Vol. 12, Núm. 11, pp. 1285-1289

  3. Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients

    Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 19, Núm. 1, pp. 55-60

1997

  1. Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 106/l

    AIDS, Vol. 11, Núm. 1, pp. 53-57

1996

  1. A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals

    Antiviral Therapy, Vol. 1, Núm. 2, pp. 105-112